$SBIG
springbig Holdings Inc

2021 Q1 Form 10-Q Financial Statement

#000114036121019768 Filed on June 03, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $0.00
YoY Change
Cost Of Revenue $1.590M
YoY Change
Gross Profit $3.620M
YoY Change
Gross Profit Margin
Selling, General & Admin $3.180M
YoY Change
% of Gross Profit 87.85%
Research & Development $1.550M
YoY Change
% of Gross Profit 42.82%
Depreciation & Amortization $10.00K
YoY Change
% of Gross Profit 0.28%
Operating Expenses $95.58K $5.025K
YoY Change 1802.05%
Operating Profit -$95.58K -$5.025K
YoY Change 1802.05%
Interest Expense $5.790K
YoY Change
% of Operating Profit
Other Income/Expense, Net -$1.968M $0.00
YoY Change
Pretax Income -$2.063M
YoY Change
Income Tax $0.00
% Of Pretax Income
Net Earnings -$2.063M $0.00
YoY Change
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$41.82K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $814.0K
YoY Change
Cash & Equivalents $814.0K $0.00
Short-Term Investments
Other Short-Term Assets $495.4K
YoY Change
Inventory
Prepaid Expenses $495.4K
Receivables
Other Receivables
Total Short-Term Assets $1.309M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $200.0M
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $200.0M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $1.309M
Total Long-Term Assets $200.0M
Total Assets $201.3M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $43.96K
YoY Change
Accrued Expenses $108.0K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $152.0K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $28.12M
YoY Change
Total Long-Term Liabilities $28.12M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $152.0K
Total Long-Term Liabilities $28.12M
Total Liabilities $28.27M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$28.15M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$26.96M $0.00
YoY Change
Total Liabilities & Shareholders Equity $201.3M
YoY Change

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income -$2.063M $0.00
YoY Change
Depreciation, Depletion And Amortization $10.00K
YoY Change
Cash From Operating Activities -$547.0K -$25.00
YoY Change 2188048.0%
INVESTING ACTIVITIES
Capital Expenditures $40.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$200.0M
YoY Change
Cash From Investing Activities -$200.0M $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $25.00K
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 201.2M 217.0K
YoY Change 92618.21%
NET CHANGE
Cash From Operating Activities -547.0K -25.00
Cash From Investing Activities -200.0M 0.000
Cash From Financing Activities 201.2M 217.0K
Net Change In Cash 628.3K 217.0K
YoY Change 189.6%
FREE CASH FLOW
Cash From Operating Activities -$547.0K -$25.00
Capital Expenditures $40.00K
Free Cash Flow -$587.0K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Accounts Payable Underwriters Promoters And Employees Other Than Salaries And Wages Current
AccountsPayableUnderwritersPromotersAndEmployeesOtherThanSalariesAndWagesCurrent
332899
CY2021Q1 us-gaap Accounts Payable Underwriters Promoters And Employees Other Than Salaries And Wages Current
AccountsPayableUnderwritersPromotersAndEmployeesOtherThanSalariesAndWagesCurrent
108000
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
0
CY2021Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
43964
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7067430
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24497
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8257666
CY2020Q4 us-gaap Assets
Assets
602835
CY2021Q1 us-gaap Assets
Assets
201315254
CY2021Q1 us-gaap Assets Current
AssetsCurrent
1309466
CY2020Q4 us-gaap Assets Current
AssetsCurrent
185752
CY2020Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
0
CY2021Q1 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
200005788
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
628291
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
216950
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
185752
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
814043
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
216950
CY2020Q4 us-gaap Cash
Cash
185752
CY2021Q1 us-gaap Cash
Cash
814043
CY2021Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="text-align: justify; font-style: italic; font-weight: bold;">Concentration of Credit Risk</div><div><br /></div><div style="text-align: justify;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such account.</div></div>
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2021Q1 us-gaap Deferred Costs
DeferredCosts
0
CY2020Q4 us-gaap Deferred Costs
DeferredCosts
417083
CY2021Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-1120000
CY2020Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
0
CY2020Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
0
CY2021Q1 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
21120000
CY2021Q1 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
22400000
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1120000
CY2020Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
CY2021Q1 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2021Q1 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2021Q1 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2021Q1 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
0
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
43964
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
495423
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
0
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
5788
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
0
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
201315254
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
602835
CY2021Q1 us-gaap Liabilities
Liabilities
28271964
CY2020Q4 us-gaap Liabilities
Liabilities
582899
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
582899
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
151964
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-547037
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-5025
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2063176
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-200000000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
201175328
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
216975
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1967598
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0
CY2020Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
250000
CY2021Q1 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
0
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
5025
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
95578
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5025
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-95578
CY2021Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
574672
CY2020Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
18025
CY2021Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
200000000
CY2020Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
0
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
0
CY2021Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
495423
CY2020Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25000
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2021Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
196000000
CY2020Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0
CY2021Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
200000000
CY2021Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
6000000
CY2020Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0
CY2021Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
6000000
CY2020Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
210000
CY2021Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0
CY2020Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001801602
CY2021Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
250000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5064
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2068240
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3258493
CY2020Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
25000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
19936
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
5000010
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
0
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
19975
CY2021Q1 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.00
CY2020Q4 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.00
CY2021Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
16804328
CY2020Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0
CY2021Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
168043280
CY2021Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
166853030
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="text-align: justify; font-style: italic; font-weight: bold;">Use of Estimates</div><div><br /></div><div style="text-align: justify;">The preparation of the condensed financial statements in conformity with GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</div><div><br /></div><div style="font-family: 'Times New Roman', Times, serif;"><font style="color: #000000;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. </font>One of the more significant accounting estimates included in these unaudited condensed financial statements is the determination of the fair value of the warrant liability. <font style="color: #000000;">Accordingly, the actual results could differ significantly from those estimates.</font></div></div>
CY2020 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
Tuatara Capital Acquisition Corp
CY2021Q1 tcac Deferred Underwriting Commissions Per Unit
DeferredUnderwritingCommissionsPerUnit
0.35
CY2021Q1 tcac Deferred Underwriting Commissions
DeferredUnderwritingCommissions
7000000
CY2021Q1 tcac Additional Units That Can Be Purchased To Cover Over Allotments
AdditionalUnitsThatCanBePurchasedToCoverOverAllotments
2625000
CY2021Q1 tcac Reclassifications Of Permanent To Temporary Equity Value
ReclassificationsOfPermanentToTemporaryEquityValue
168043280
CY2021Q1 tcac Founder Shares Forfeited Value
FounderSharesForfeitedValue
0
CY2021Q1 tcac Period To Exercise Warrants After Closing Of Initial Public Offering
PeriodToExerciseWarrantsAfterClosingOfInitialPublicOffering
P12M
CY2021Q1 tcac Trading Day Period To Calculate Volume Weighted Average Trading Price Following Notice Of Redemption
TradingDayPeriodToCalculateVolumeWeightedAverageTradingPriceFollowingNoticeOfRedemption
P10D
CY2021Q1 tcac Period For Registration Statement To Become Effective
PeriodForRegistrationStatementToBecomeEffective
P60D
CY2021Q1 tcac Period To Exercise Warrants After Business Combination
PeriodToExerciseWarrantsAfterBusinessCombination
P30D
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Shell Company
EntityShellCompany
true
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2020Q1 tcac Transaction Costs Allocated To Warrant Liabilities
TransactionCostsAllocatedToWarrantLiabilities
0
CY2021Q1 tcac Transaction Costs Allocated To Warrant Liabilities
TransactionCostsAllocatedToWarrantLiabilities
853386
CY2020Q4 tcac Deferred Underwriting Fee Payable Non Current
DeferredUnderwritingFeePayableNonCurrent
0
CY2021Q1 tcac Deferred Underwriting Fee Payable Non Current
DeferredUnderwritingFeePayableNonCurrent
7000000
CY2021Q1 tcac Shares Issued In Initial Public Offering During Period Value New Issues
SharesIssuedInInitialPublicOfferingDuringPeriodValueNewIssues
175086530
CY2021Q1 tcac Class Of Warrant Or Right Threshold Trigger Price For Redemption
ClassOfWarrantOrRightThresholdTriggerPriceForRedemption
10.00
CY2021Q1 tcac Period To File Registration Statement After Initial Business Combination
PeriodToFileRegistrationStatementAfterInitialBusinessCombination
P15D
CY2021Q1 tcac Payment Of Formation Costs Through Promissory Note By Sponsor
PaymentOfFormationCostsThroughPromissoryNoteBySponsor
0
CY2020Q1 tcac Payment Of Formation Costs Through Promissory Note By Sponsor
PaymentOfFormationCostsThroughPromissoryNoteBySponsor
5000
CY2020Q1 tcac Payment Of Offering Costs Through Promissory Note
PaymentOfOfferingCostsThroughPromissoryNote
35000
CY2021Q1 tcac Payment Of Offering Costs Through Promissory Note
PaymentOfOfferingCostsThroughPromissoryNote
0
CY2021Q1 tcac Deferred Underwriting Fee Charged To Additional Paid In Capital
DeferredUnderwritingFeeChargedToAdditionalPaidInCapital
7000000
CY2020Q1 tcac Deferred Underwriting Fee Charged To Additional Paid In Capital
DeferredUnderwritingFeeChargedToAdditionalPaidInCapital
0
CY2021Q1 tcac Offering Costs Included In Accrued Offering Costs
OfferingCostsIncludedInAccruedOfferingCosts
108000
CY2020Q1 tcac Offering Costs Included In Accrued Offering Costs
OfferingCostsIncludedInAccruedOfferingCosts
237099
CY2020Q1 tcac Initial Classification Of Common Stock Subject To Redemption
InitialClassificationOfCommonStockSubjectToRedemption
0
CY2021Q1 tcac Initial Classification Of Common Stock Subject To Redemption
InitialClassificationOfCommonStockSubjectToRedemption
166853030
CY2021Q1 tcac Change In Value Of Ordinary Shares Subject To Possible Redemption
ChangeInValueOfOrdinarySharesSubjectToPossibleRedemption
1190250
CY2020Q1 tcac Change In Value Of Ordinary Shares Subject To Possible Redemption
ChangeInValueOfOrdinarySharesSubjectToPossibleRedemption
0
CY2021Q1 tcac Stock Conversion As Converted Percentage
StockConversionAsConvertedPercentage
0.2
CY2021Q1 tcac Stock Conversion Ratio
StockConversionRatio
1
CY2021Q1 tcac Offering Costs
OfferingCosts
11766856
CY2021Q1 tcac Offering Costs
OfferingCosts
11766856
CY2021Q1 tcac Underwriting Fees
UnderwritingFees
4000000
CY2021Q1 tcac Underwriting Fees Deferred
UnderwritingFeesDeferred
7000000
CY2021Q1 tcac Other Offering Costs
OtherOfferingCosts
766856
CY2021Q1 tcac Period To Prior To The Completion Of Business Combination
PeriodToPriorToTheCompletionOfBusinessCombination
P2D
CY2021Q1 tcac Percentage Of Public Shares That Would Not Be Redeemed If Business Combination Is Not Completed Within Initial Combination Period
PercentageOfPublicSharesThatWouldNotBeRedeemedIfBusinessCombinationIsNotCompletedWithinInitialCombinationPeriod
1
CY2021Q1 tcac Cash Deposited In Trust Account Per Unit
CashDepositedInTrustAccountPerUnit
10.00
CY2021Q1 tcac Net Tangible Asset Threshold For Redeeming Public Shares
NetTangibleAssetThresholdForRedeemingPublicShares
5000001
CY2021Q1 tcac Period To Complete Business Combination From Closing Of Initial Public Offering
PeriodToCompleteBusinessCombinationFromClosingOfInitialPublicOffering
P24M
CY2021Q1 tcac Period To Redeem Public Shares If Business Combination Is Not Completed Within Initial Combination Period
PeriodToRedeemPublicSharesIfBusinessCombinationIsNotCompletedWithinInitialCombinationPeriod
P10D
CY2021Q1 tcac Percentage Of Public Shares That Can Be Redeemed Without Prior Consent
PercentageOfPublicSharesThatCanBeRedeemedWithoutPriorConsent
0.15
CY2021Q1 tcac Option For Underwriters To Purchase Additional Units Term
OptionForUnderwritersToPurchaseAdditionalUnitsTerm
P45D
CY2021Q1 tcac Excess Of Fair Value Of Warrants Over Purchase Price
ExcessOfFairValueOfWarrantsOverPurchasePrice
2400000
CY2021Q1 tcac Percentage For Warrant Holders To Accept Tender Offer
PercentageForWarrantHoldersToAcceptTenderOffer
0.5
CY2021Q1 tcac Offering Costs Of Initial Public Offering
OfferingCostsOfInitialPublicOffering
10913470

Files In Submission

Name View Source Status
0001140361-21-019768-index-headers.html Edgar Link pending
0001140361-21-019768-index.html Edgar Link pending
0001140361-21-019768.txt Edgar Link pending
0001140361-21-019768-xbrl.zip Edgar Link pending
brhc10025208_10q.htm Edgar Link pending
brhc10025208_ex31-1.htm Edgar Link pending
brhc10025208_ex31-2.htm Edgar Link pending
brhc10025208_ex32-1.htm Edgar Link pending
brhc10025208_ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tcac-20210331.xml Edgar Link completed
tcac-20210331.xsd Edgar Link pending
tcac-20210331_cal.xml Edgar Link unprocessable
tcac-20210331_def.xml Edgar Link unprocessable
tcac-20210331_lab.xml Edgar Link unprocessable
tcac-20210331_pre.xml Edgar Link unprocessable